| review article | Q7318358 |
| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Jane S. Hocking | Q37374045 |
| Christopher K. Fairley | Q37374066 | ||
| Catriona S Bradshaw | Q56810078 | ||
| Fabian Yuh Shiong Kong | Q61857637 | ||
| Marcus Y Chen | Q90408823 | ||
| P2093 | author name string | Dyani Lewis | |
| Andrew Lau | |||
| P2860 | cites work | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic | Q21133562 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis | Q24605678 | ||
| The Epidemiology of Chlamydia trachomatis Organism Load During Genital Infection: A Systematic Review | Q26827366 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Association between Mycoplasma genitalium and acute endometritis | Q28206155 | ||
| Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography | Q29615697 | ||
| Persistence of Mycoplasma genitalium following azithromycin therapy | Q33382111 | ||
| Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis | Q34245136 | ||
| Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! | Q34390759 | ||
| Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study | Q34615260 | ||
| Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey | Q35008363 | ||
| Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial | Q35019879 | ||
| Mycoplasma genitalium: from Chrysalis to multicolored butterfly | Q35090137 | ||
| Mycoplasma genitalium: should we treat and how? | Q35542157 | ||
| Azithromycin failure in Mycoplasma genitalium urethritis | Q35792616 | ||
| Mycoplasma genitalium presence, resistance and epidemiology in Greenland | Q36159575 | ||
| The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection | Q36551190 | ||
| Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial | Q36656274 | ||
| Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline | Q36930455 | ||
| Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium | Q36971250 | ||
| Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. | Q37056118 | ||
| A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London | Q37572093 | ||
| Asymptomatic Mycoplasma genitalium infection amongst marginalised young people accessing a youth health service in Melbourne | Q37845882 | ||
| Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum among students in northern Norway | Q37849099 | ||
| In vitro activity of azithromycin against Mycoplasma genitalium and its efficacy in the treatment of male Mycoplasma genitalium-positive nongonococcal urethritis | Q37850695 | ||
| Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study | Q37852187 | ||
| Clinical efficacy of azithromycin for male nongonococcal urethritis | Q37855943 | ||
| Prevalence of Mycoplasma genitalium, Mycoplasma hominis and Chlamydia trachomatis among Danish patients requesting abortion | Q37857245 | ||
| Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. | Q37859666 | ||
| A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men. | Q37860416 | ||
| Mucopurulent cervicitis and Mycoplasma genitalium | Q37870078 | ||
| Serological investigation of Mycoplasma genitalium in infertile women | Q37873556 | ||
| Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication | Q37876651 | ||
| Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort | Q38237332 | ||
| Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women | Q40084684 | ||
| Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens | Q41583528 | ||
| Mycoplasma genitalium and its resistance to azithromycin in incarcerated men from Far North Queensland. | Q41658678 | ||
| A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. | Q42170059 | ||
| Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. | Q42212384 | ||
| Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance | Q43004634 | ||
| Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance | Q43722862 | ||
| Single-dose azithromycin treatment for Mycoplasma genitalium-positive urethritis: best but not good enough. | Q46014385 | ||
| Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance | Q46260038 | ||
| Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study | Q46340504 | ||
| Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial | Q46954398 | ||
| Detection of macrolide resistance in Mycoplasma genitalium in France | Q48048222 | ||
| Induction of beta-lactamase and methicillin resistance in unusual strains of methicillin-resistant Staphylococcus aureus. | Q54336018 | ||
| Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. | Q54342664 | ||
| Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. | Q54359754 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | azithromycin | Q165399 |
| Mycoplasma genitalium | Q1930909 | ||
| P304 | page(s) | 1389-1399 | |
| P577 | publication date | 2015-08-03 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis | |
| P478 | volume | 61 |
| Q37836494 | 2016 European guideline on the management of non-gonococcal urethritis |
| Q40397194 | Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance |
| Q50880789 | Editorial Commentary: Mycoplasma genitalium and Declining Treatment Efficacy of Azithromycin 1 g: What Can We Do? |
| Q97075335 | Emerging macrolide resistance in Mycoplasma genitalium |
| Q92503169 | Evaluation of the ResistancePlus MG FleXible Assay for Detection of Wild-Type and 23S rRNA-Mutated Mycoplasma genitalium Strains |
| Q54324481 | Evaluation of the SpeeDx ResistancePlus MG Diagnostic Test for Mycoplasma genitalium on the Applied Biosystems 7500 Fast Quantitative PCR Platform. |
| Q37611991 | Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium |
| Q40346692 | High prevalence of the A2058T macrolide resistance-associated mutation in Mycoplasma genitalium strains from the Netherlands |
| Q89775903 | High prevalence of vaginal and rectal Mycoplasma genitalium macrolide resistance among female STD clinic patients in Seattle, Washington |
| Q33597030 | Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium |
| Q57035503 | Long duration of asymptomatic Mycoplasma genitalium infection after syndromic treatment for nongonococcal urethritis |
| Q64239107 | Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014 |
| Q40359795 | Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection |
| Q53812158 | Multidrug-Resistant Mycoplasma genitalium Is Increasing. |
| Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
| Q40071927 | Mycoplasma genitalium Infection in Men. |
| Q89444103 | Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama |
| Q94450769 | Mycoplasma genitalium in Singapore is associated with Chlamydia trachomatis infection and displays high macrolide and Fluoroquinolone resistance rates |
| Q64111407 | Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance |
| Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
| Q49874388 | Mycoplasma genitalium non-adherent phase variants arise by multiple mechanisms and escape antibody-dependent growth inhibition |
| Q90111635 | Mycoplasma genitalium, a stealth female reproductive tract |
| Q40071934 | Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment |
| Q26748959 | Mycoplasma genitalium: An Emerging Sexually Transmitted Infection |
| Q26747053 | Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women? |
| Q88503965 | Mycoplasma genitalium: yet another challenging STI |
| Q38609857 | New Horizons in Mycoplasma genitalium Treatment |
| Q90157182 | No pathogen-specific sign or symptom predicts the etiology of monomicrobial nongonococcal urethritis in men |
| Q30240049 | Non-viral sexually transmitted infections - Epidemiology, clinical manifestations, diagnostics and therapy : Part 2: Chlamydia and mycoplasma |
| Q37833830 | Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis |
| Q33562762 | Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia |
| Q97075329 | Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis |
| Q57457111 | STI with Mycoplasma genitalium-more common than Chlamydia trachomatis in patients attending youth clinics in Sweden |
| Q57054894 | Sensitive and specific assay for the simultaneous detection of Mycoplasma genitalium and macrolide resistance-associated mutations |
| Q37833827 | Sexually transmitted infections: challenges ahead |
| Q39193385 | Should azithromycin 1 g be abandoned as a treatment for bacterial STIs? The case for and against. |
| Q47140897 | Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model |
| Q40515694 | Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report |
| Q50129445 | Symptomatic urethritis should be confirmed by microscopy |
| Q49755869 | Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection |
| Q37835240 | What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies |
| Q89530439 | [Recurrent Urogynecological Infections] |
Search more.